Literature DB >> 27593409

Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.

Takeshi Sato1, Tsubasa Okano1, Mari Tanaka-Kubota1, Shunsuke Kimura1, Satoshi Miyamoto1, Shintaro Ono1, Motoi Yamashita1, Noriko Mitsuiki1, Masatoshi Takagi2, Kohsuke Imai2, Michiko Kajiwara3, Takasuke Ebato4, Shohei Ogata4, Hirotsugu Oda5, Osamu Ohara5,6, Hirokazu Kanegane7, Tomohiro Morio1.   

Abstract

Severe combined immunodeficiency (SCID) is the most severe form of primary immunodeficiency disease, and it is characterized by marked impairment in cellular and humoral immunity. Mutations in several genes cause SCID, one of which is Janus kinase 3 (JAK3), resulting in autosomal recessive T(-)B(+)NK(-) SCID. Only three patients with JAK3-deficient SCID have been reported in Japan. We herein describe the case of a 6-month-old girl with pneumocystis pneumonia, who was diagnosed with SCID with compound heterozygous JAK3 mutations (c.1568G>A + c.421-10G>A). One of the mutations was previously reported in another Japanese patient. The other mutation was a novel and de novo relatively deep intronic mutation causing aberrant RNA splicing. The patient was successfully treated with bone marrow transplantation from a haploidentical donor.
© 2016 Japan Pediatric Society.

Entities:  

Keywords:  Janus kinase 3; compound heterozygous mutation; severe combined immunodeficiency

Mesh:

Substances:

Year:  2016        PMID: 27593409     DOI: 10.1111/ped.13070

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  3 in total

Review 1.  Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.

Authors:  Akira Nishimura; Satoshi Miyamoto; Kohsuke Imai; Tomohiro Morio
Journal:  Int J Hematol       Date:  2022-06-08       Impact factor: 2.490

2.  Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases.

Authors:  Akira Nishimura; Yuki Aoki; Yasuyoshi Ishiwata; Takuya Ichimura; Junichi Ueyama; Yuta Kawahara; Takahiro Tomoda; Maiko Inoue; Kazuaki Matsumoto; Kento Inoue; Haruka Hiroki; Shintaro Ono; Motoi Yamashita; Tsubasa Okano; Mari Tanaka-Kubota; Miho Ashiarai; Satoshi Miyamoto; Reiji Miyawaki; Chika Yamagishi; Mari Tezuka; Teppei Okawa; Akihiro Hoshino; Akifumi Endo; Masato Yasuhara; Takahiro Kamiya; Noriko Mitsuiki; Toshiaki Ono; Takeshi Isoda; Masakatsu Yanagimachi; Daisuke Tomizawa; Masayuki Nagasawa; Shuki Mizutani; Michiko Kajiwara; Masatoshi Takagi; Hirokazu Kanegane; Kohsuke Imai; Tomohiro Morio
Journal:  J Clin Immunol       Date:  2021-02-01       Impact factor: 8.317

Review 3.  Chronic active Epstein-Barr virus infection as the initial symptom in a Janus kinase 3 deficiency child: Case report and literature review.

Authors:  Linqing Zhong; Wei Wang; Mingsheng Ma; Lijuan Gou; Xiaoyan Tang; Hongmei Song
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.